202 related articles for article (PubMed ID: 36403403)
1. Invasive mucormycosis in a tertiary care hospital in the western region of Saudi Arabia: 11-year retrospective chart review from 2009 to 2019.
Almarhabi H; Al-Asmari E; Munshi A; Farahat F; Al-Amri A; Almaghraby HQ; Alharbi M; Althaqafi A
J Infect Public Health; 2022 Dec; 15(12):1466-1471. PubMed ID: 36403403
[TBL] [Abstract][Full Text] [Related]
2. Mucormycosis: An 8-year experience of a tertiary care centre in Saudi Arabia.
Elzein F; Albarrag A; Kalam K; Arafah M; Al-Baadani A; Eltayeb N; Aloteibi F; Alrashed A; Abdullah RA; Alasiri S
J Infect Public Health; 2020 Nov; 13(11):1774-1779. PubMed ID: 32891591
[TBL] [Abstract][Full Text] [Related]
3. Mucormycosis at a tertiary-care center in Mexico. A 35-year retrospective study of 214 cases.
Bonifaz A; Tirado-Sánchez A; Hernández-Medel ML; Araiza J; Kassack JJ; Del Angel-Arenas T; Moisés-Hernández JF; Paredes-Farrera F; Gómez-Apo E; Treviño-Rangel RJ; González GM
Mycoses; 2021 Apr; 64(4):372-380. PubMed ID: 33253454
[TBL] [Abstract][Full Text] [Related]
4. Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries.
Pana ZD; Seidel D; Skiada A; Groll AH; Petrikkos G; Cornely OA; Roilides E;
BMC Infect Dis; 2016 Nov; 16(1):667. PubMed ID: 27832748
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and outcome of mucormycosis: A multi-center retrospective analysis in Saudi Arabia over 11 years.
Abanamy R; Alsaud A; Alabdulali R; Alsobaie M; Alalwan B; Aljohani S; Alshieban S; Turkistani H; Almohaizeie A; Bosaeed M; AlRabiah F
IJID Reg; 2022 Sep; 4():152-156. PubMed ID: 35941863
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of mucormycosis in north India: experience from a tertiary care hospital.
Bala K; Chander J; Handa U; Punia RS; Attri AK
Med Mycol; 2015 Apr; 53(3):248-57. PubMed ID: 25587084
[TBL] [Abstract][Full Text] [Related]
7. [Mucormycosis: retrospective evaluation of 12 cases].
Arda B; Erdem A; Sipahi OR; Işıkgöz Taşbakan M; Pullukçu H; Taşbakan MS; Ceylan N; Metin DY; Midilli R; Yamazhan T; Ulusoy S
Mikrobiyol Bul; 2011 Jul; 45(3):504-11. PubMed ID: 21935783
[TBL] [Abstract][Full Text] [Related]
8. Paediatric cutaneous mucormycosis: A case report and review of the literature.
Ziaka M; Papakonstantinou E; Vasileiou E; Chorafa E; Antachopoulos C; Roilides E
Mycoses; 2022 Jul; 65(7):674-682. PubMed ID: 35514044
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran.
Abdorahimi M; Pakdel F; Salehi M; Alcazar-Fuoli L; Hashemi SJ; Daie Ghazvini R; Ahmadkhani F; Ahmadikia K; Abdollahi A; Debran JCS; Tabari A; Farrokh F; Mousavand A; Afarinesh Khaki P; Salami Khaneshan A; Ibrahim AS; Khodavaisy S
Mycopathologia; 2023 Oct; 188(5):783-792. PubMed ID: 37672164
[TBL] [Abstract][Full Text] [Related]
10. A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).
Lanternier F; Dannaoui E; Morizot G; Elie C; Garcia-Hermoso D; Huerre M; Bitar D; Dromer F; Lortholary O;
Clin Infect Dis; 2012 Feb; 54 Suppl 1():S35-43. PubMed ID: 22247443
[TBL] [Abstract][Full Text] [Related]
11. Mucormycosis at a tertiary care centre in Gujarat, India.
Patel AK; Patel KK; Patel K; Gohel S; Chakrabarti A
Mycoses; 2017 Jun; 60(6):407-411. PubMed ID: 28276102
[TBL] [Abstract][Full Text] [Related]
12. Mucormycosis caused by Apophysomyces species: An experience from a tertiary care hospital in Western India and systematic review of global cases.
Samaddar A; Shrimali T; Sharma A
Mycoses; 2023 Mar; 66(3):181-195. PubMed ID: 36227645
[TBL] [Abstract][Full Text] [Related]
13. Healthcare burden of probable and proven invasive mucormycosis: a multi-centre cost-of-illness analysis of patients treated in tertiary care hospitals between 2003 and 2016.
Heimann SM; Vehreschild MJGT; Cornely OA; Heinz WJ; Grüner B; Silling G; Kessel J; Seidel D; Vehreschild JJ
J Hosp Infect; 2019 Mar; 101(3):339-346. PubMed ID: 30423409
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology, clinical features, therapeutic interventions and outcomes of mucormycosis in Shiraz: an 8-year retrospective case study with comparison between children and adults.
Motamedi M; Golmohammadi Z; Yazdanpanah S; Saneian SM; Shafiekhani M
Sci Rep; 2022 Oct; 12(1):17174. PubMed ID: 36229497
[TBL] [Abstract][Full Text] [Related]
15. Mucormycosis experience through the eyes of the laboratory.
Sağıroğlu P; Nedret Koç A; Atalay MA; Altinkanat Gelmez G; Canöz Ö; Mutlu Sarıgüzel F
Infect Dis (Lond); 2019 Oct; 51(10):730-737. PubMed ID: 31364897
[No Abstract] [Full Text] [Related]
16. [Evaluation of zygomycosis cases by pooled analysis method reported from Turkey].
Zeka AN; Taşbakan M; Pullukçu H; Sipahi OR; Yamazhan T; Arda B
Mikrobiyol Bul; 2013 Oct; 47(4):708-16. PubMed ID: 24237440
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of 3 cases of mucormycosis in children with acute lymphoblastic leukemia and literature review].
Sun HY; Li B; Liu Y; You HL; Liu YF
Zhonghua Er Ke Za Zhi; 2022 Jan; 60(1):56-61. PubMed ID: 34986625
[No Abstract] [Full Text] [Related]
18. Mucormycosis in Mainland China: A Systematic Review of Case Reports.
Wei LW; Zhu PQ; Chen XQ; Yu J
Mycopathologia; 2022 Feb; 187(1):1-14. PubMed ID: 34855101
[TBL] [Abstract][Full Text] [Related]
19. Nasal Mucormycosis: Our experience with 24 cases.
Bakshi SS; Das S; Ramesh S; Gopalakrishnan S
Otolaryngol Pol; 2020 Feb; 74(4):37-40. PubMed ID: 32636347
[TBL] [Abstract][Full Text] [Related]
20. Invasive Mucormycosis in Children With Malignancies: Report From the Infection Working Group of the Hellenic Society of Pediatric Hematology-Oncology.
Antoniadi K; Iosifidis E; Vasileiou E; Tsipou C; Lialias I; Papakonstantinou E; Kattamis A; Polychronopoulou S; Roilides E; Tragiannidis A
J Pediatr Hematol Oncol; 2021 Jul; 43(5):176-179. PubMed ID: 32890077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
